Evidence map›Paper›PMID 35578791›Full record

ArticleAnalytical chemistry2022

Polyhedral Particles with Controlled Concavity by Indentation Templating.

Daniel W Weisgerber, Makiko Hatori, Xiangpeng Li, Adam R Abate

Abstract read
In one paragraph

Article in Analytical chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Daniel W WeisgerberDepartment of Bioengineering and Therapeutic Sciences University of California, San Francisco 1700 Fourth Street, San Francisco, California 94158, United States.ORCID 0000-0003-3187-634X
Makiko HatoriDepartment of Bioengineering and Therapeutic Sciences University of California, San Francisco 1700 Fourth Street, San Francisco, California 94158, United States.
Xiangpeng LiDepartment of Bioengineering and Therapeutic Sciences University of California, San Francisco 1700 Fourth Street, San Francisco, California 94158, United States.
Adam R AbateDepartment of Bioengineering and Therapeutic Sciences University of California, San Francisco 1700 Fourth Street, San Francisco, California 94158, United States.ORCID 0000-0001-9614-4831

Funding

Gigapixel digital PCR in Giant Unilamellar VesiclesR01EB019453 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ABATE, ADAM R., CHIU, CHARLES YEN · 2014 to 2022
$3.9M
SINGLE-CELL TRANSCRIPTOMIC ANALYSIS OF HIV-INFECTED CD4 T CELLS IN BLOOD AND LYMPHOID TISSUE USING PCR-ACTIVATED CELL SORTINGU01AI129206 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ABATE, ADAM R., BORITZ, ELI A · 2017 to 2020
$1.6M
NIAID NIH HHS U01 AI129206NIBIB NIH HHS R01 EB019453
6 · The paper itself

Abstract

Current methods for fabricating microparticles offer limited control over size and shape. Here, we demonstrate a droplet microfluidic method to form polyhedral microparticles with controlled concavity. By manipulating Laplace pressure, buoyancy, and particle rheology, we generate microparticles with diverse shapes and curvatures. Additionally, we demonstrate the particles provide increased capture efficiency when used for particle-templated emulsification. Our approach enables microparticles with enhanced chemical and biological functionality.

Indexed as

Microfluidic Analytical TechniquesMicrofluidicsParticle SizeRheology

Identifiers

PMID35578791
PMCPMC9161221

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.